Site hosted by Angelfire.com: Build your free website today!

ANGELMAN SYNDROME



A chromosomal disorder resulting in a syndrome characterized by :

*** dysmorphic facial features

with neurological and behavioural manifestations.




PATHOGENESIS:

1. Historical Perspectives

2. Genetic Defect

1. Cytogentic Findings (Anomaly (%))

CLINICAL FEATURES:

1. Neurological Manifestations

2. Facial Dysmorphisms*

* absent at birth but become evident by 5 years of age

3. Behavioural Manifestations

4. Musculoskeletal Manifestations

5. Other Manifestations

INVESTIGATIONS:

1. Imaging Studies

1. CT/MRI

2. EEG

MANAGEMENT:

1. Supportive

2. Prognosis

ADDITIONAL REFERENCES:

1. J. Med. Gen 29:412 (1992)
2. Angelman Syndrome Support Group of Canada
3. Am. J. of Med. Gen. 35:314 (1990)

INTERNET LINKS:

Angelman Syndrome: A Parent's Guide
Angelman Syndrome Foundation, USA
Angels Among Us

National Institutes of Health, Bethesda, Maryland 20892

Written September 1997

ANGELMAN SYNDROME


Index:


DESCRIPTION: Angelman syndrome is a neurological disorder characterized by severe congenital mental retardation, unusual facial appearance, and muscular abnormalities. Symptoms of Angelman syndrome include unstable jerky gait, hand flapping, unusually happy demeanor, developmental delay, lack of or diminished speech, and microcephaly (small head). Epilepsy may develop in the early years of life, however it may decrease with age. Patients may also have balance problems.

Return to Index


TREATMENT: There is no standard course of treatment for Angelman syndrome. Physical therapy and adaptive devices may help patients with jerky gait. Early language evaluation and intervention is often recommended. Anticonvulsant medications may be prescribed for epilepsy.
PROGNOSIS: Most individuals with Angelman syndrome will have mental delay, severe speech limitations, and some type of gait abnormality. Patients may have improvement of symptoms with therapy.
RESEARCH: The NINDS supports research on Angelman syndrome. The purpose of this research is to continue genetic analysis of the disorder by isolating and characterizing the Angelman syndrome gene(s).


These articles, available from a medical library, are sources of in-depth information on Angelman syndrome:

Boyd, S, et al. "The EEG in Early Diagnosis of the Angelman (Happy Puppet) Syndrome." European Journal of Pediatrics, 147; 508-513 (1988).

Clayton-Smith, J. "Clinical Research on Angelman Syndrome in the United Kingdom: Observations on 82 Affected Individuals." American Journal of Medical Genetics, 46; 12-15 (1993).

Robb, S, et al. "The ‘Happy Puppet’ Syndrome of Angelman: Review of the Clinical Features." Archives of Disease in Childhood, 64; 83-86 (1989).

Zori, R, et al. "Angelman Syndrome: Clinical Profile." Journal of Child Neurology, 7; 270-280 (July 1992).

PROFILE A - Z GENETIC CONDITIONS





Reprinted From the AGSA Newsletter with the permission of The Association

of Genetic Support of Australia





ANGELMAN SYNDROME

Angleman Syndrome is a neurological disorder associated with mental delay

and characteristic facial appearance and behaviour. It affects

approximately 1 in 20,000 individuals. In 1965, Dr Harry Angelman, an

English physician, first reported his f1ndings on three children with

similar characteristics now known as Angelman Syndrome.





Angelman Syndrome is most often diagnosed by a paediatric neurologist or

geneticist. It is diff1cult to diagnose a child with Angelman Syndrome

under 12 months of age. Som individuals have not been diagnosed until late

childhood or adulthood.





The main characteristics of Angelman Syndrome include:





* mental retardation

* speech impairment - little or no speech and limited communication skills

* movement or balance disorder - children with Angelman Syndrome usually

have an unsteady, stiff gait with legs wide and arms uplifted. Balance

improves in some individuals with age. Hand tremulousness is also common

* happy, smiling disposition children will laugh easily

* epilepsy

* hyperactivity

* flattened back of the head

* drooling and excessive chewing

* hypopigmented skin - light hair and eye colour

* small widely spaced teeth

* wide mouth, protruding tongue with prominent jaw.





Not all characteristics need to be present to obtain a positive diagnosis

of Angelman Syndrome.





Genetics





Angleman Syndrome is caused by a deleted or missing segment in the proximal

portion of the long arm of chromosome 15. Every person has two number 15

chromosomes, one inherited from each parent. In many children with Angelman

Syndrome an abnormality can be demonstrated by either directly examining

the number 15 chromosome under a microscope or by using molecular

diagnostic methods to examine the chromosomes - DNA. In a small percentage

of individuals two chromosome 15's have been inherited from the father and

none from the mother thus causing Angelman Syndrome.





Hovever in 10-20% of Angelman Syndrome children, no abnormality has yet to

be found on their chromosome 15, but the abnormality may be too small to

identify with present technology. Thus a normal or negative study does not

necessarily mean that a child does not have Angelman Syndrome.





Maternal But Not Paternal Transmission of 15q11-13-Linked Nondeletion Angelman Syndrome Leads to Phenotypic Expression

J. Wagstaff J, J.H. Knoll, K.A. Glatt, Y.Y. Shugart, A. Sommer, M. Lalande

Nature Genetics 1(4), 291--294 (1992 Jul)

Abstract

Angelman syndrome (AS) may result from either maternally inherited deletions of chromosome 15q11-13 or from paternal uniparental disomy for chromosome 15. This is in contrast to Prader-Willi syndrome (PWS), which is caused by either paternal deletion of this region or maternal disomy for chromosome 15. However, 40% of AS patients inherit an apparently intact copy of chromosome 15 from each parent. We now describe a family in which three sisters have given birth to four AS offspring who have no evidence of deletion or paternal disomy. We show that AS in this family is caused by a mutation in 15q11-13 that results in AS when transmitted from mother to child, but no phenotype when transmitted paternally. These results suggest that the loci responsible for AS and PWS, although closely linked, are distinct.